These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33392381)

  • 1. LDL cholesterol and uridine levels in blood are potential nutritional biomarkers for clinical progression in Alzheimer's disease: The NUDAD project.
    de Leeuw FA; Tijms BM; Doorduijn AS; Hendriksen HMA; van de Rest O; de van der Schueren MAE; Visser M; van den Heuvel EGHM; van Wijk N; Bierau J; van Berckel BN; Scheltens P; Kester MI; van der Flier WM; Teunissen CE
    Alzheimers Dement (Amst); 2020; 12(1):e12120. PubMed ID: 33392381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific Nutritional Biomarker Profiles in Mild Cognitive Impairment and Subjective Cognitive Decline Are Associated With Clinical Progression: The NUDAD Project.
    de Leeuw FA; van der Flier WM; Tijms BM; Scheltens P; Mendes VM; Manadas B; Bierau J; van Wijk N; van den Heuvel EGHM; Mohajeri MH; Teunissen CE; Kester MI
    J Am Med Dir Assoc; 2020 Oct; 21(10):1513.e1-1513.e17. PubMed ID: 32001171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly.
    Slot RE; Van Harten AC; Kester MI; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; Veerhuis R; van der Flier WM
    J Alzheimers Dis; 2017; 56(2):687-697. PubMed ID: 28035918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional Status Is Associated With Clinical Progression in Alzheimer's Disease: The NUDAD Project.
    Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Hendriksen HMA; Teunissen CE; Scheltens P; van der Flier WM; Visser M
    J Am Med Dir Assoc; 2023 May; 24(5):638-644.e1. PubMed ID: 33239240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    Scarth M; Rissanen I; Scholten RJPM; Geerlings MI
    J Alzheimers Dis; 2021; 83(3):1089-1111. PubMed ID: 34397412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer's disease.
    Pillai JA; Bena J; Bekris L; Kodur N; Kasumov T; Leverenz JB; Kashyap SR;
    Alzheimers Res Ther; 2023 Mar; 15(1):54. PubMed ID: 36927447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrients required for phospholipid synthesis are lower in blood and cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease dementia.
    van Wijk N; Slot RER; Duits FH; Strik M; Biesheuvel E; Sijben JWC; Blankenstein MA; Bierau J; van der Flier WM; Scheltens P; Teunissen CE
    Alzheimers Dement (Amst); 2017; 8():139-146. PubMed ID: 28653034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Homocysteine and Serum Folate and Vitamin B
    Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer's Disease Patients.
    Berezhnoy G; Laske C; Trautwein C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline.
    Verfaillie SC; Tijms B; Versteeg A; Benedictus MR; Bouwman FH; Scheltens P; Barkhof F; Vrenken H; van der Flier WM
    Alzheimers Dement (Amst); 2016; 5():43-52. PubMed ID: 28054027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of multivariable prediction models for institutionalization and mortality in the full spectrum of Alzheimer's disease.
    Mank A; van Maurik IS; Rijnhart JJM; Bakker ED; Bouteloup V; Le Scouarnec L; Teunissen CE; Barkhof F; Scheltens P; Berkhof J; van der Flier WM
    Alzheimers Res Ther; 2022 Aug; 14(1):110. PubMed ID: 35932034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort.
    Orellana A; García-González P; Valero S; Montrreal L; de Rojas I; Hernández I; Rosende-Roca M; Vargas L; Tartari JP; Esteban-De Antonio E; Bojaryn U; Narvaiza L; Alarcón-Martín E; Alegret M; Alcolea D; Lleó A; Tárraga L; Pytel V; Cano A; Marquié M; Boada M; Ruiz A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
    Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
    J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline.
    Stark M; Wolfsgruber S; Kleineidam L; Frommann I; Altenstein S; Bartels C; Brosseron F; Buerger K; Burow L; Butryn M; Ewers M; Fliessbach K; Gabelin T; Glanz W; Goerss D; Gref D; Hansen N; Heneka MT; Hinderer P; Incesoy EI; Janowitz D; Kilimann I; Kimmich O; Laske C; Munk MH; Perneczky R; Peters O; Preis L; Priller J; Rauchmann BS; Rostamzadeh A; Roy-Kluth N; Sanzenbacher C; Schneider A; Schott BH; Spottke A; Spruth EJ; Teipel S; Vogt IR; Wiltfang J; Duzel E; Jessen F; Wagner M
    Neurology; 2023 Nov; 101(21):e2185-e2196. PubMed ID: 37821235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.